Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review)

per Wyganowska-Świątkowska, Marzena, Tarnowski, Mateusz, Murtagh, Daniel, Skrzypczak-Jankun, Ewa, Jankun, Jerzy
Publicat a Int J Mol Med (2019)

Neoadjuvant chemotherapy for high‐risk prostatic adenocarcinoma

per Brunner, Robert, Buck, Bradley, Giffen, Zane, Murtagh, Daniel, Lewis, Terrence, Gatto‐Weis, Cara, Sindhwani, Puneet
Publicat a IJU Case Rep (2019)

A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients

per Brikun, Igor, Nusskern, Deborah, Gillen, Daniel, Lynn, Amy, Murtagh, Daniel, Feczko, John, Nelson, William G, Freije, Diha
Publicat a Biomark Res (2014)